This article provides a scientific overview of autologous cell concentrates (ACCs), biological products derived from a patient's own cells for therapeutic applications.
This article provides a detailed comparison of autologous and allogeneic cell therapies for researchers, scientists, and drug development professionals.
This article provides a holistic analysis of how cryopreservation protocols impact the critical quality attributes (CQAs) of cell therapies, from research through commercialization.
This article provides a comprehensive guide for researchers and drug development professionals on designing and executing long-term stability studies for cryopreserved cell therapy intermediates.
For researchers and drug development professionals in cell and gene therapy, achieving consistent cryopreservation outcomes is critical for therapeutic efficacy and regulatory compliance.
This article provides a comprehensive analysis for researchers and drug development professionals on the critical choice between traditional DMSO-containing and emerging DMSO-free cryopreservation media.
This comprehensive review synthesizes current evidence on the impact of cryopreservation on cellular phenotype and function, a critical consideration for biomedical research and cell-based therapies.
This article provides a comprehensive analysis of controlled-rate and passive freezing methodologies for cell therapy intermediates.
This article provides researchers, scientists, and drug development professionals with a comprehensive guide to temperature mapping strategies for cryopreservation equipment.
This article provides a critical analysis for researchers and drug development professionals on the use of fresh versus cryopreserved peripheral blood mononuclear cells (PBMCs) as starting material for Chimeric Antigen...